Umbilical Cord-derived Wharton's Jelly

BIOLOGICAL3 trials

Sponsors

BioIntegrate

Conditions

Erectile DysfunctionOsteoarthritis, Knee

Early Phase 1

Umbilical Cord Derived Wharton's Jelly for Knee Osteoarthritis

BioIntegrateOsteoarthritis, Knee

Start: 2023-01-01End: 2024-12-31Target: 12Updated: 2022-07-21

Phase 1

DualStim Therapy With or Without Umbilical Cord Derived Wharton's Jelly for Erectile Dysfunction

BioIntegrateErectile Dysfunction

Start: 2023-01-01End: 2024-12-31Target: 60Updated: 2022-07-21

Evaluation of Safety and Efficacy of Wharton's Jelly Compared to Hyaluronic Acid and Saline for Knee Osteoarthritis.

Not yet recruitingNCT04711304

BioIntegrateOsteoarthritis, Knee

Start: 2023-01-01End: 2026-06-01Target: 168Updated: 2022-07-21

Related Papers

Safety and efficacy of umbilical cord-derived Wharton’s jelly compared to hyaluronic acid and saline for knee osteoarthritis: study protocol for a randomized, controlled, single-blind, multi-center trial

Journal of Orthopaedic Surgery and Research2021-05-3127 citations

Umbilical cord-derived Wharton’s jelly for treatment of knee osteoarthritis: study protocol for a non-randomized, open-label, multi-center trial

Journal of Orthopaedic Surgery and Research2021-02-1838 citations